Strategy For Limiting Risks Human Health Draft of ... - ECHA - Europa

More documents

Recommendations

Info

fax: +49(231)9071-2679 e-mail: chemg@baua.bund.de 2
CONTENT 0 SUMMARY 5 1 BACKGROUND 7 2 THE RISK ASSESSMENT 12 2.1 Workers 12 2.2 Consumers 29 3 CURRENT RISK REDUCTION MEASURES 35 3.1 Workers 36 3.2 Consumers 38 4 POSSIBLE FURTHER RISK REDUCTION MEASURES 39 4.1 Workers 39 4.2 Consumers 39 5 ASSESSMENT OF POSSIBLE FURTHER RISK REDUCTION MEASURES 40 5.1 Workers 40 5.2 Consumers 44 6 FURTHER RISK REDUCTION MEASURES RECOMMENDED 45 6.1 Workers 45 3
Page 1: TRISODIUM HEXAFLUOROALUMINATE (Cryo
Page 5 and 6: 0 Summary Trisodium hexafluoroalumi
Page 7 and 8: 1 Background In the framework of EU
Page 9 and 10: By-production in aluminium smelters
Page 11 and 12: Company Location(s) Alcoa Aviles Sp
Page 13 and 14: Table 2.1: Occupational exposure le
Page 15 and 16: Comparison of MOS and reference MOS
Page 17 and 18: Repeated dose toxicity Local effect
Page 19 and 20: was established at 0.5 mg/m 3 (6h/d
Page 21 and 22: Combined exposure For all exposure
Page 23 and 24: Developmental toxicity Cryolite was
Page 25 and 26: Table 2.4 Developmental toxicity, p
Page 27 and 28: Tables 2.6 (inhalation) and 2.7 (de
Page 29 and 30: Table 2.7: Ranking of health risks
Page 31 and 32: Respiratory tract Regarding the sen
Page 33 and 34: and the analog sodium fluoride (NTP
Page 35 and 36: 3 Current Risk Reduction Measures C
Page 37 and 38: Country OEL (mg/m 3 STEL ) (mg/m 3
Page 39 and 40: 4 Possible Further Risk Reduction M
Page 41 and 42: Scenario 2: Use of cryolite in the
Page 43 and 44: Technical and organisational measur
Page 45: 6 Further Risk Reduction Measures R

Strategy For Limiting Risks Human Health Draft of ... - ECHA - Europa

Create successful ePaper yourself

Delete template?

Save as template?